Abstract P-glycoprotein (P-gp), encoded by the ABCB1/ MDR1 gene, is a drug transporter at the blood-brain barrier. Several polymorphisms in the ABCB1 gene are known to affect the activity and/or expression of P-gp, thereby influencing the treatment response and toxicity of P-gp substrates like citalopram and venlafaxine. In this study, we aimed to investigate the frequency of ABCB1 genotypes in forensic autopsy cases involving these two antidepressants. Further, the distribution of ABCB1 genotypes in deaths related to intoxication was compared to cases not associated to drug intoxication. The study included 228 forensic autopsy cases with different causes and manners of deaths. The ABCB1 single nucleotide polymorphisms (SNPs) G1199A, C1236T, C3435T and G2677T/A for these individuals were determined. The SNPs C1236T and C3435T in venlafaxinepositive cases were significantly different between the intoxication cases and non-intoxications. This was not seen for cases involving citalopram, indicating that the effect of genetic variants might be substrate specific. This novel finding should, however, be confirmed in future studies with larger number of cases.
Introduction
Postmortem genetic testing (molecular autopsy) has been suggested to provide insights for the interpretation of forensic toxicological results [1] [2] [3] [4] . So far, much research has focused on cytochrome P450 polymorphisms [5] [6] [7] [8] [9] [10] [11] . There is now a need for studies on the possible impact of other genetic polymorphisms in forensic autopsy cases.
P-glycoprotein (P-gp), encoded by the ABCB1 gene (also known as MDR1), is expressed in the endothelium of blood capillaries of the brain (blood-brain barrier; BBB) as well as in the kidneys and the intestine [12] . In order for drugs to exert its effects on the central nervous system, the drug has to pass the BBB. In the BBB P-gp acts as an efflux pump, which removes its substrates from the brain back into the bloodstream and is capable of extruding drugs with different chemical structures and mechanisms of action, such as antidepressants and antipsychotics [13] [14] [15] [16] [17] [18] [19] [20] . Venlafaxine and citalopram are antidepressant drugs and substrates of P-gp. While citalopram belongs to the pharmacodynamic class of selective serotonin reuptake inhibitors (SSRIs), venlafaxine belongs to the class of dual serotonin and noradrenaline reuptake inhibitors [21] .
The ABCB1 gene is located in the human chromosome 7 band p21-21.1 [22] . Three of the identified single nucleotide polymorphisms (SNPs) in the ABCB1 gene, C3435T, G2677T/A and C1236T, are believed to affect the activity Electronic supplementary material The online version of this article (doi:10.1007/s00414-013-0849-0) contains supplementary material, which is available to authorized users. and/or expression level of the protein [23] [24] [25] . The SNPs have also been associated with altered pharmacokinetics and treatment response [26] [27] [28] . Clinical efficiency of antidepressant as well as antipsychotic treatment has been correlated with ABCB1 genetic polymorphisms and substrate properties of several drugs [28] [29] [30] [31] . To our knowledge, only two studies focusing on the influences of P-gp genotype in postmortem samples have been published [32, 33] , and so far none on antidepressant drugs.
Interpretation of postmortem results is not always an easy task [34] , and studies focused on the use of genotyping in the forensic case work are warranted. The overall aim of the present study was to investigate the frequency of ABCB1 genotypes in forensic autopsy cases positive for citalopram or venlafaxine. Further, the distribution of ABCB1 genotypes in deaths related to intoxication was compared to cases not associated to drug intoxication.
Methods

Case selection
From the Department of Forensic Genetics and Forensic Toxicology in Linköping, Sweden, 228 cases positive for venlafaxine and citalopram (venlafaxine n=116, citalopram n=112) during the toxicological screening were identified and genotyped for ABCB1 SNPs. At the time of the study, the cases were routinely screened for medical substances and ethanol (screening for illegal drugs was only performed upon request). All included cases were classified using International Classification of Disease-9 (ICD-9) codes by the responsible forensic pathologist and divided into intoxications (n=73: suicides, accidents and undetermined; ICD codes E950, E980, E859 and E866) and cases not related to drug intoxication (n=155: non-intoxications; comprising all other causes of death not related to intoxications). Information related to each of the cases (age, gender and other circumstances surrounding death) was provided from the forensic pathology and toxicology databases at the Swedish National Board of Forensic Medicine. Demographic characteristics of the individuals are presented in Table 1 . The study was approved by the Regional Ethical Review Board in Linköping, Sweden.
Toxicological analysis
Routine screening of a wide range of prescription drugs was determined in femoral blood by capillary gas chromatography with nitrogen-phosphorus detector. In brief, two different extraction methods were used: an alkaline and a neutral extraction. One gram of femoral blood was used in both extraction procedures and standard curves, made by adding known amounts of each analyte to drug-free blood, were used for the quantification of drugs [35] . The concentrations of venlafaxine (plus the main metabolite Odesmethylvenlafaxin) and citalopram (plus the main metabolite desmethylcitalopram) were quantified by using this method. Ethanol was determined in blood according to a previously described method [36] .
Genotyping for ABCB1
The following ABCB1 SNPs, G1199A (exon 11, rs2229109), C1236T (exon 12, rs1128503), G2677T/A (exon 21, rs2032582) and C3435T (exon 26, rs1045642) were identified by PCR and pyrosequencing. In brief, genomic DNA was extracted using King Fischer ML (Thermo Scientific, Vantaa, Finland). Extracted DNA was stored frozen in −20°C until analysed. PCR and sequencing primers were designed using the PSQAssay Design program (Qiagen, Uppsala, Sweden). PCR primers, sequencing primers and dispensation order for the four SNPs are shown in Table 2 . For PCR amplification, the reactions were optimized for MgCl 2 concentration (1.5 mM) and annealing temperature (58°C), and each primer was used at a final concentration of 0.4 μM. HotStarTaq master mixture (VWR International, Stockholm, Sweden) was used, and all reactions were performed on a Mastercycler gradient instrument (Eppendorf, Hamburg, Germany) in a total volume of 12.5 μl. The four SNPs were analysed using a PyroMark Q96MD instrument (Qiagen, Uppsala, Sweden) according to the manufacturer's protocol.
Statistics
Statistical differences between groups were calculated using the Fisher's exact test. The distributions of individual homozygous variant were compared to individuals with the wild-type or heterozygous genotype. A p value<0.05 was considered statistically significant. All statistical analyses were performed using StatView® (SAS® Institute, Cary; NC, version 5.0).
Results
General results
The study includes 116 cases positive for venlafaxine and 112 cases positive for citalopram. The general characteristics of the cases, analytical results, including concentrations of parent drug and main metabolite, age, sex, cause and manner of death, are presented in Table 1 . The material comprised 85 women (37 %) and 143 men (63 %) in total with ages ranging between 18 and 90 years (median, 56 years). Ninety-one different substances were detected (median number of drugs were 4; range, 1-11). In 39 cases (17 %), venlafaxine or citalopram was the only drug identified, and none of the cases were classified as intoxications. The median concentration of venlafaxine was 0.50 μg/g and for the main metabolite O-desmethylvenlafaxine 0.30 μg/g. For the citalopram-positive cases, the median citalopram concentration was 0.40 μg/g and for the main metabolite desmethylcitalopram 0.10 μg/g. Most frequently found drugs in addition to venlafaxine and citalopram are displayed in Table 3 . According to the forensic pathologist, the death was related to intoxication (suicide, accident or undetermined) in 73 cases (32 % of all cases). A total of 103 cases were classified as suicides (45 % of all cases), and 35 of these cases were associated with intoxication (34 % of all suicides). The remaining 68 suicide cases were not associated with drug intoxication, and hanging was the most frequently cause of death (n=45) followed by drowning (n=11). The manner of death was considered natural in 51 cases, and the 57 cases were classified as accidents. The age, sex, drug and metabolite concentrations in relation to other found drugs and cause and manner of death, in all individual G1199A  CTTTTCGAGATGGGTAA  GACTCGAGTGAC  C1236T  TGCACCTTCAGGTTCA  TGAGCTCAGAT  G2677T/A  TTAGTTTGACTCACCTTCC  GCCAGTCAGCTC  C3435T CTTTGCTGCCCTCAC CAGAGTCTCT cases, are presented in Tables S1 and S2 of the Electronic supplementary material. The genotype frequencies of the ABCB1 gene are given in Table 4 . All the 228 cases, with exception of 3 cases for C1236T, were successfully genotyped for the SNPs (G1199A, C1236T, C2677T/A and C3435T) and did not significantly deviate from the Hardy-Weinberg equilibrium.
ABCB1 genotypes in intoxication and non-intoxication cases
The frequencies of the ABCB1 genotypes in intoxications (n=73; comprising suicides, accidents and undetermined intoxication cases) and non-intoxications (n=155; comprising all other causes of deaths not related to intoxication) are presented in Table 5 . The SNPs C1236T and C3435T in venlafaxine-positive cases were significantly different between the intoxication cases and the non-intoxication cases (C1236T p=0.0173; C3435T p=0.0074). The same trend was observed for G2677T in venlafaxine-positive cases, but the comparison did not reach statistical significance (p= 0.0597). Very few individuals positive for venlafaxine were homozygous variants for the SNPs (i.e. individuals 1236TT, 2677TT or 3435TT) in the intoxication cases as compared to the other cases. The genetic variant 1236 and 3435 was significantly different between intoxications and nonintoxications in the whole (citalopram+venlafaxine) material. For the SNP G1199A, a low frequency of the A variant was found, and the genotype distribution was not significantly different between intoxications and non-intoxications (no A/A homozygous individuals was found). Very few cases were found to carry the 2677A variant so they were excluded from the analysis. No significant difference in ABCB1 genotype distribution was seen for the citaloprampositive cases.
Discussion
Accidental deaths caused by drugs may rely on various causes, including variations in accumulation of drug and therapeutic response. Transport proteins may play an Table 3 Most frequently found drugs (n) in addition to venlafaxine and citalopram in the postmortem cases divided into intoxications (comprising suicide, accidents and undetermined intoxication cases) and non-intoxications (comprising all other causes of deaths not related to intoxication) (13) Zopiclone (12) Zopiclone (11) Mirtazapine (7) Diazepam (12) Alimemazine (10) Nordiazepam (6) Alimemazine (6) Nordiazepam (8) Paracetamol (10) Paracetamol (5) Diazepam (5) a Propiomazine and/or dihydropropiomazine essential role in drug toxicity and efficacy. The knowledge about the distribution of relevant polymorphisms in the gene of e.g. ABCB1 in a population might be valuable information when understanding the cause and manner of deaths in forensic cases. Therefore, we investigated the frequencies of four SNPs in the ABCB1 gene to evaluate whether the distribution differed between intoxication and nonintoxication deaths. In the present population, we found that the genotype distribution of C1236T, G2677T and C3435T differed in intoxication cases as compared to nonintoxication cases involving venlafaxine. In humans, P-gp is present in several tissues that are important for drug absorption, distribution and elimination [37] . With regard to the effect of the SNPs on antidepressants, few studies are available. Uhr and colleagues published a clinical study of ABCB1 polymorphisms in depressed patients and provided the first evidence that genetic variants account for differences in the clinical efficacy of antidepressants [28] . They found an association between SNPs in ABCB1 and remission in patients taking P-gp substrates (including venlafaxine and citalopram). This is in accordance with our findings that the ABCB1 genotype might influence antidepressant response.
To our knowledge, only two studies with postmortem samples and genotyping for SNPs in ABCB1 have so far been published. The effect of three SNPs (C1236T, G2677T and C3435T) on postmortem digoxin concentration in 112 subjects was studied, and they found that the T-T-T haplotype allele frequency was higher in the group with high digoxin concentration (≥7 nmol/l) and that the females might have a higher risk of digoxin intoxication [33] . In a study with methadone, no association between the SNPs and methadone concentrations or metabolite concentration was found [32] . In our study, we found an association between ABCB1 genotype and drug intoxication in cases involving venlafaxine. This was not seen for cases positive for citalopram, indicating that the effect of genetic variants might be substrate specific.
In the venlafaxine-positive cases in the present study, the intoxication group contained no homozygous variant individuals (1236 TT n=0; 2677 TT n=1 and 3435 TT n=4). In this forensic material, a carrier homozygous variant for 1236, 2677 and/or 3435 is more likely to have died by suicide not associated with drug intoxication (1236 TT, 73 % suicides; 2677 TT, 67 % suicides and 3435 TT 57 % suicides) and hanging being the most common cause of death. Of the individuals with the TT-TT-TT (1236-2677-3435) haplotype, 70 % (7/10 cases) were suicides (six hangings and one drowning), and none of them were associated with intoxication (suicide, accident or undetermined). If these cases are associated with low therapeutic effects (assuming that they are on medication for depression), severe side effects or a behavioral phenotype leading to the individuals being more prone to suicide remains to be elucidated. Of the individuals with homozygous variant for one of the SNPs (2677 TT n=1 and 3435 TT n=4) in the intoxication group, two were suicides by intoxication, one accident and one undetermined (all cases had venlafaxine concentration at the higher end of the therapeutic range). The published studies on the effect of ABCB1 polymorphisms on the effects of antidepressants are inconclusive [38] [39] [40] [41] . The studies have not been consistently performed, and the role of ABCB1 polymorphisms in pharmacokinetics and pharmacodynamics needs to be further studied. Recently, a study reported that polymorphisms in the ABCB1 gene are associated with the severity of depression and the effectiveness of the antidepressant escitalopram [42] . The influence of ABCB1 polymorphism on the disposition of the Sand R-enantiomers of citalopram in plasma and cerebrospinal fluid (CSF) was examined under steady-state conditions in 15 patients with major depression treated with citalopram. The 2677 TT genotype was associated with lower plasma and CSF concentrations than the 2677GT or 2677GG. The 2677 GG/GT genotype was associated with a better treatment response (p=0.001) compared with the 2677TT genotype [43] . Others have not found any associations between SNPs and treatment or drug concentrations. Menu et al. studied whether the response to antidepressants in 117 depressed patients differed in patients with the 3435CC genotype as compared to patients with the 3435CT and 3435TT genotypes. They found no association between the SNP and antidepressant efficacy or tolerance [44] . In another paper where the associations between ABCB1 polymorphisms and citalopram response and tolerance were studied, no association was found [45] .
When dealing with intoxication cases, it is important to consider not only the measured drug concentrations but also possible co-factors that can influence the interpretation of the toxicological results. According to several studies, venlafaxine has a relatively higher fatal toxicity compared with SSRIs and other newer antidepressants [46] [47] [48] [49] . Different explanations regarding this finding have been suggested. Launiainen et al. recently reported that fatal venlafaxine poisonings were associated with a high prevalence of drug interactions [50] . This is in line with results previously reported by us [7] and also evident from the present data. The most frequently found prescription drugs, in addition to venlafaxine and citalopram, were zopiclone, paracetamol, propiomazine/dihydropropiomazine, diazepam, alimemazine, nordiazepam and mirtazapine. The present results support the importance of considering adverse drug combinations as one of the major risk factors leading to fatal drug intoxications [51, 52] . In this context, it should also be noted that among the newer antidepressants, like venlafaxine and citalopram, differences are present both in toxicity and in interaction potential with alcohol [53] .
Studies of genetic factors that might influence the risk of intoxication are of value in forensic toxicology. In our postmortem study with 228 cases, we found that the genotype distribution of SNPs C1236T and C3435T significantly differed between intoxications and nonintoxications indicating that these polymorphisms might influence the function of P-gp leading to toxicity risk (i. e. high drug concentration in the brain) or unsatisfied therapeutic effect due to low drug concentration in the brain. However, our novel findings should be replicated in future studies with larger groups of cases and with other antidepressants.
